• Venn Therapeutics on Twitter
  • Venn Therapeutics on LinkedIn

©2017 BY VENN THERAPEUTICS LLC.

Tampa, FL, USA

OUR TEAM
Board of Directors

Sam Shrivastava

 

Sam Shrivastava currently serves as Venn Therapeutics' Chief Executive Officer and the Chairman of the Board of Directors. 

Joseph Lobacki

 

Joseph Lobacki currently serves as Venn Therapeutics' President and Chief Operating Officer in addition to his role as a member of the Board of Directors. 

Paul Krysiak

 

Mr. Krysiak is a strong business leader with 17 years of biopharmaceutical industry experience focused on rare diseases and oncology. Currently, he serves as the President & CEO of Seva Therapeutics, an innovative oncology company. His previous experience includes CEO of 3G Therapeutics, VP of Sales and Business Development at EmpiraMed, VP of Commercial and Operations at Ceerdis Corporation, Area Director & GM at BioMarin Pharmaceuticals, as well as progressive sales and marketing management roles at Genzyme Corporation. Mr. Krysiak started his career in general and specialty sales at Merck.

 

Mr. Krysiak obtained a B.S. in both Biomedical Sciences and Biochemistry from the University of Guelph and a M.S. in Molecular Physiology from the University of Western Ontario. He has also received executive business training from the Ivey Business School.

Bruce Hrovat

 

Bruce Hrovat has served as a member of our board of directors since 2016. Mr. Hrovat is a seasoned banker and has designed the future regulatory state of one of the eight largest banks in the United States and implemented new intraday regulations impacting payments and reporting. He has led a 5,000+ branch network as Teller Executive, was the Chief Operations Officer of a top 20 USA Regional Bank and led Global Transaction Banking for a top 20 Global Transaction Bank driving nearly $400 billion of payments each day. Bruce is highly experienced in Retail, Commercial and Wholesale Banking.

 

Mr. Hrovat holds a Bachelor’s of Science from Marietta College in Economics and Petroleum Engineering.

Howard Winston

 

Howard Winston has served as a member of our board of directors since 2016. Mr. Winston is the Partner at Montrose Capital Group, LLC and a consultant to several family offices with significant assets. Formerly, he was a Principal at Waveland Capital Management, L.P. Mr. Winston focuses on special situation investment opportunities.

 

Mr. Winston holds a Bachelor’s of Arts in Economics from Emory University and an MBA from University of Cincinnati College of Business.

Please reload